(From left) Doctoral student Hannah Yamagata, research assistant professor Kushol Gupta, and postdoctoral fellow Marshall Padilla holding 3D-printed models of nanoparticles.
(Image: Bella Ciervo)
Scientists at the University of Pennsylvania explain how a class of RNA molecules is able to target the genetic building blocks that guide the functioning of a specific part of the nerve cell. Abnormalities at this site are in involved in epilepsy, neurodegenerative disease, and cognitive disorders. Their results are published this week in the journal Neuron.
A team of researchers, led by James Eberwine, PhD, the Elmer Bobst Professor of Pharmacology in the School of Medicine, and Junhyong Kim, PhD, the Edmund J. and Louise W. Kahn Professor of Biology in the School of Arts and Sciences, looked at how RNA gets targeted to nerve cell dendrites, which branch from the cell body of the neuron and detect the electrical and chemical signals transmitted by the axons of other neurons. These studies were enabled through the use of sensitive single cell analysis techniques developed in the Eberwine lab.
Click here to view the full release.
Karen Kreeger
(From left) Doctoral student Hannah Yamagata, research assistant professor Kushol Gupta, and postdoctoral fellow Marshall Padilla holding 3D-printed models of nanoparticles.
(Image: Bella Ciervo)
Jin Liu, Penn’s newest economics faculty member, specializes in international trade.
nocred
nocred
nocred